T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis

Mucosal Immunology

Volumn 9, Issue 6, 2016, Pages 1487-1499

  Zimmermann, J ^a   Kuhl A A ^b   Weber, M ^a   Grun J R ^a   Loffler J ^a   Haftmann, C ^a   Riedel, R ^a   Maschmeyer, P ^a   Lehmann, K ^a   Westendorf, K ^a   Mashreghi, M F ^a   Lohning M ^a   Mack, M ^c   Radbruch, A ^a   Chang, H D ^a  

^a POTSDAM INSTITUTE FOR CLIMATE IMPACT RESEARCH PIK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 17; TRANSCRIPTION FACTOR T BET; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL ISOLATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL FEATURE; COLITIS; CONTROLLED STUDY; DIARRHEA; DISEASE CLASSIFICATION; DISEASE EXACERBATION; HELICOBACTER HEPATICUS; HISTOPATHOLOGY; INFLAMMATION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL; UPREGULATION; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; GENETICS; HELPER CELL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE COUNT; MACROPHAGES; MICE; MICE, KNOCKOUT; MONOCYTES; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS;

EID: 84991704796     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.5     Document Type: Article

References (51)

1. Saro, C., & Aladré n, B.S. Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing? World J. Gastroenterol. 14, 5491 (2008
2. Burt, R.K., et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 116, 6123-6132 (2010
3. Stronkhorst, A. et al.CD4antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study. Gut 40, 320-327 (1997
4. Powrie, F., Leach, M.W., Mauze, S., Caddle, L.B., & Coffman, R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461-1471 (1993
5. Feng, T.,Wang, L., Schoeb, T.R., Elson, C.O., & Cong, Y. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 207, 1321-1332 (2010
6. Neurath, M.F., et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195, 1129-1143 (2002
7. Szabo, S.J., et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000
8. Szabo, S.J. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338-342 (2002
9. Schulz, E.G., Mariani, L., Radbruch, A., & Hofer, T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-γ and interleukin-12. Immunity 30, 673-683 (2009
10. Lazarevic, V., Glimcher, L.H., & Lord, G.M. T-bet: a bridge between innate and adaptive immunity. Nat. Rev. Immunol. 13, 1-13 (2013
11. Fuss, I.J., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157, 1261-1270 (1996
12. Powrie, F., et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ Tcells. Immunity 1, 553-562 (1994
13. Simpson, S.J., et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 187, 1225-1234 (1998
14. Gokmen,M.R., et al. Genome-WideRegulatory Analysis Reveals That T-bet Controls Th17 Lineage Differentiation through Direct Suppression of IRF4. J. Immunol. 191, 5925-5932 (2013
15. Leppkes, M., et al. RORg-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17 A and IL-17 F. Gastroenterology 136, 257-267 (2009
16. Durant, L., et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32, 605-615 (2010
17. Stepankova, R., et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm. Bowel Dis. 13, 1202-1211 (2007
18. Ivanov, I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009
19. Cahill, R.J. et al. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65, 3126-3131 (1997
20. Wojciechowski, S., et al. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J. Exp. Med. 204, 1665-1675 (2007
21. Wang, C., Kang, S.G., Lee, J., Sun, Z., & Kim, C.H. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol. 2, 173-183 (2009
22. Asseman, C., Read, S., & Powrie, F. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol. 171, 971-978 (2003
23. Griseri, T., Asquith, M., Thompson, C., & Powrie, F. OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med. 207, 699-709 (2010
24. Haftmann, C., et al. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim. Eur. J. Immunol. 45, 1192-1205 (2014
25. Annunziato, F., et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849-1861 (2007
26. Ciofani, M., et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012
27. Duhen, R., et al. Cutting edge: the pathogenicity of IFN-g -producing Th17 cells is independent of T-bet. J. Immunol. 190, 4478-4482 (2013
28. Yuan, X., et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med. 205, 3133-3144 (2008
29. Durrant, D.M., Gaffen, S.L., Riesenfeld, E.P., Irvin, C.G., & Metzger, D.W. Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J. Immunol. 183, 5293-5300 (2009
30. Lazarevic, V., et al. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgt. Nat. Immunol. 12, 96-104 (2011
31. Neurath, M.F. Cytokines in inflammatory boweldisease. Nat. Rev. Immunol. 14, 329-342 (2014
32. Lee, J.S., et al. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. Immunity 43, 1-13 (2015
33. Maxwell, J.R., et al. Differential Roles for Interleukin-23 and Interleukin- 17 in Intestinal Immunoregulation. Immunity 43, 1-13 (2015
34. Usui, T., et al. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 203, 755-766 (2006
35. Sullivan, B.M., et al. Increased Susceptibility of Mice Lacking T-bet to Infection with Mycobacterium tuberculosis Correlates with Increased IL-10 and Decreased IFN- Production. J. Immunol. 175, 4593-4602 (2005
36. Sabet-Baktach, M., et al. Double deficiency for ROR t and T-bet drives Th2-mediated allograft rejection in mice. J. Immunol. 191, 4440-4446 (2013
37. Intlekofer, A.M., et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408-411 (2008
38. Wang, Y., et al. The transcription factors T-bet and runx are required for the ontogeny of pathogenic interferon-g-producing T helper 17 cells. Immunity 40, 1-12 (2014
39. Bregenholt, S., Brimnes, J., Nissen, M.H., & Claesson, M.H. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts. Clin. Exp. Immunol. 118, 228-234 (1999
40. Vonarbourg, C., et al. Regulated expression of nuclear receptor RORgt confers distinct functional fates to NK cell receptor-expressing RORgt+ innate lymphocytes. Immunity 33, 736-751 (2010
41. Buonocore, S., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010
42. Griseri, T., McKenzie, B.S., Schiering, C., & Powrie, F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 37, 1-14 (2012
43. Wang, N., Liang, H., & Zen, K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol. 5, 614 (2014
44. Coccia, M., et al. IL-1 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells. J. Exp. Med. 209, 1595-1609 (2012
45. Corazza, N., Eichenberger, S., Eugster, H.P., & Mueller, C. Nonlymphocytederived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-)mice upon transfer of CD4(+) CD45RB(hi) T cells. J. Exp. Med. 190, 1479-1492 (1999
46. Ahern, P.P., et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279-288 (2010
47. Niesner, U., et al. Autoregulation of Th1-mediated inflammation by twist1. J. Exp. Med. 205, 1889-1901 (2008
48. Brühl, H., et al. Targeting of Gr-1+,CCR2+ monocytes in collageninduced arthritis. Arthritis Rheum. 56, 2975-2985 (2007
49. Sanos, S.L., &Diefenbach, A. Isolation ofNKcells and NK-like cells from the intestinal lamina propria. Methods Mol. Biol. 612, 505-517 (2010
50. Zimmermann, J., Radbruch, A., & Chang, H.-D. A concentration of 1.5mM, as present in IMDMbut not in RPMI, is critical formaximal response of Th cells to PMA/ionomycin. Eur. J. Immunol. 45, 1270-1273 (2015
51. Biesen, R., et al. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum. 58, 1136-1145 (2008